Tocilizumab in patients with moderate or severe COVID-19: a randomized, controlled, open-label, multicenter trial. - Wang D; Fu B; Peng Z; Yang D; Han M; Li M; Yang Y; Yang T; Sun L; Li W; Shi W; Yao X; et al. (Frontiers of medicine, 2021)